Bruno Lucidi

Insider Reports History

Entity
Individual
Location
C/O Atea Pharmaceuticals, Inc., 125 Summer Street, Boston, MA
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Bruno Lucidi
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bruno Lucidi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Atea Pharmaceuticals, Inc. Director Common Stock 83.2K $333K $4.00 Jun 16, 2024 Direct
Atea Pharmaceuticals, Inc. Director Restricted Stock Units 29.6K $103K $3.49 Jun 21, 2024 Direct
Atea Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 41.2K Jun 21, 2024 Direct

Insider Reports Filed by Bruno Lucidi

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVIR Atea Pharmaceuticals, Inc. Jun 21, 2024 2 $0 4 Jun 21, 2024 Director
AVIR Atea Pharmaceuticals, Inc. Jun 16, 2024 2 $0 4 Jun 18, 2024 Director
AVIR Atea Pharmaceuticals, Inc. Jun 16, 2023 2 $0 4 Jun 21, 2023 Director
AVIR Atea Pharmaceuticals, Inc. Jun 17, 2022 1 $0 4 Jun 21, 2022 Director
AVIR Atea Pharmaceuticals, Inc. Jun 18, 2021 1 $0 4 Jun 21, 2021 Director